Myomo (MYO) EBT Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -300.13% |
| Jun 30, 2025 | -344.90% |
| Mar 31, 2025 | 11.33% |
| Dec 31, 2024 | 5.09% |
| Sep 30, 2024 | 55.54% |
| Jun 30, 2024 | 0.97% |
| Mar 31, 2024 | -44.26% |
| Dec 31, 2023 | 366.82% |
| Sep 30, 2023 | 29.35% |
| Jun 30, 2023 | 65.09% |
| Mar 31, 2023 | 4.99% |
| Dec 31, 2022 | 18.85% |
| Sep 30, 2022 | -37.95% |
| Jun 30, 2022 | -11.89% |
| Mar 31, 2022 | 6.61% |
| Dec 31, 2021 | -129.66% |
| Sep 30, 2021 | 26.70% |
| Jun 30, 2021 | 20.70% |
| Mar 31, 2021 | 22.86% |
| Dec 31, 2020 | 497.99% |
| Sep 30, 2020 | 0.46% |
| Jun 30, 2020 | -28.09% |
| Mar 31, 2020 | -46.32% |
| Dec 31, 2019 | 18.79% |
| Sep 30, 2019 | -4.69% |
| Jun 30, 2019 | 2.54% |
| Mar 31, 2019 | -10.05% |
| Dec 31, 2018 | -67.69% |
| Sep 30, 2018 | -80.15% |
| Jun 30, 2018 | -26.57% |
| Mar 31, 2018 | -54.14% |
| Dec 31, 2017 | -9.04% |
| Sep 30, 2017 | -74.05% |
| Jun 30, 2017 | -236.92% |